0 Commentaires
0 Parts
357 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Biosimulation Market Demand Rises With Growing Focus on Precision Drug DevelopmentA drug candidate can spend years moving through discovery, preclinical testing, and clinical development before researchers know whether it will ultimately succeed. That uncertainty is one of the central problems that the Biosimulation Market is increasingly addressing. Instead of relying entirely on physical experiments to understand how a drug may behave, researchers can use...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Brazil Pharmaceutical Industry Market – Generic Drug Expansion Driving AccessibilityMarket Overview The Brazil Pharmaceutical Industry Market is experiencing sustained growth as generic drug penetration increases pharmaceutical accessibility across Latin America's largest economy. Government policies promoting bioequivalence, price regulation mechanisms, and public procurement programs have established Brazil as a major generic pharmaceutical market. The market is projected to...0 Commentaires 0 Parts 798 Vue 0 Aperçu
-
Competitive Landscape of the Onychomycosis Drug Market: Key Players and Strategic MovesThe onychomycosis drug market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. With the market projected to reach USD 9.84 billion by 2035, understanding the strategies of key players is essential for anyone tracking the industry's evolution. Competition is intense, with companies pursuing...0 Commentaires 0 Parts 428 Vue 0 Aperçu
-
Drug Discovery Platforms: The Future of Organ-on-Chip TechnologyThe integration of organ-on-chip technology into drug discovery platforms is revolutionizing the development of new therapies, offering a more predictive and ethical approach to drug testing. Drug discovery platforms are essential for identifying and developing new therapeutic agents, and organ-on-chip technology is a key component of modern platforms. The organ chips market is...0 Commentaires 0 Parts 713 Vue 0 Aperçu
-
Drug Injection Systems: The Evolving Injectable Drug Delivery MarketThe delivery of injectable medications has been transformed by advances in device technology, improving patient experience and treatment outcomes. Drug injection systems are essential for the effective administration of biologics, vaccines, and other therapies that require parenteral delivery. The drug injection systems market is experiencing substantial growth, with projections from...0 Commentaires 0 Parts 488 Vue 0 Aperçu
-
From Diagnostics to Drug Discovery: Clinical Applications Driving the Laboratory Equipment MarketThe clinical applications of laboratory equipment span diverse healthcare and research settings, from routine diagnostics to cutting-edge genomics and drug discovery. The Laboratory Equipment Market is benefiting from this diverse demand, valued at USD 35.20 billion in 2025 and projected to reach USD 77.42 billion by 2035 at a CAGR of 8.2%. This article explores the clinical...0 Commentaires 0 Parts 799 Vue 0 Aperçu
-
How Are Drug-Coated Balloons Transforming Peripheral Vascular Intervention?Peripheral vascular intervention has traditionally relied on balloon angioplasty and stenting. While effective, both approaches have limitations: plain balloon angioplasty carries a high risk of restenosis, and stents introduce permanent metal implants that can fracture or require complex reintervention. Drug-coated balloons are transforming peripheral intervention by combining the simplicity...0 Commentaires 0 Parts 30 Vue 0 Aperçu
-
Intelligent Design: How AI-Powered Drug Discovery Is Revolutionizing Pharmaceutical DevelopmentThe AI-Driven Drug Discovery Market is experiencing explosive growth as AI-powered drug discovery continues to revolutionize pharmaceutical development and therapeutic innovation. According to market reports, the global AI-Driven Drug Discovery Market was valued at USD 2.48 billion in 2024 and is projected to reach USD 40.0 billion by 2035, exhibiting an extraordinary CAGR of 28.8%...0 Commentaires 0 Parts 810 Vue 0 Aperçu
-
Intrathecal Pumps Market – Targeted Drug Delivery Revolutionizing Chronic PainMarket Overview The Intrathecal Pumps Market is experiencing substantial momentum as healthcare stakeholders recognize the transformative potential of innovative therapeutic and technological solutions. Market expansion is underpinned by rising disease prevalence, evolving patient expectations, and regulatory frameworks that increasingly favor advanced interventions over conventional...0 Commentaires 0 Parts 455 Vue 0 Aperçu
-
Intravaginal Drug Delivery: Innovations in Women's Therapeutic SolutionsIntravaginal drug delivery represents a sophisticated and effective method for administering medication directly to the vaginal cavity, offering targeted therapy with reduced systemic side effects. Intravaginal drug delivery systems, including rings, inserts, and implants, are designed to provide sustained and controlled release of hormones, contraceptives, and other therapeutic...0 Commentaires 0 Parts 367 Vue 0 Aperçu
-
Investment Opportunities in the Non-Steroidal Anti-Inflammatory Drug MarketThe Non-Steroidal Anti-Inflammatory Drug Market presents steady investment opportunities in the pharmaceutical sector, characterized by consistent demand and evolving product innovation. Valued at $37.19 billion in 2024, the market is projected to reach $50.01 billion by 2035, driven by aging populations and rising chronic pain prevalence. Investment Drivers The rising prevalence of...0 Commentaires 0 Parts 653 Vue 0 Aperçu
-
Proteomics Market Trends Drive Innovation in Clinical ResearchThe role of proteomics is changing as life sciences research moves toward more detailed and personalized understanding of biology. Instead of examining proteins in isolation, researchers are increasingly looking at expression patterns, interactions, biomarkers, and molecular pathways to understand disease and therapeutic response. This broader role is creating new demand for technologies that...0 Commentaires 0 Parts 958 Vue 0 Aperçu
-
Regulatory Affairs Services and Drug Development Support: Building a Comprehensive Life Sciences FrameworkThe management of drug development requires a sophisticated approach that combines effective regulatory affairs services with comprehensive drug development support. At the core of this approach are Regulatory Affairs Services , which provide the specialized expertise needed for successful regulatory submissions and compliance. The global life sciences BPO market, valued at USD 531.2...0 Commentaires 0 Parts 985 Vue 0 Aperçu
-
3D Printed Drug Market to Reach USD 438.39 Million by 2034, Growing at a CAGR of 14.94%The global 3D Printed Drug Market is gaining significant traction, driven by advancements in additive manufacturing technologies and the growing demand for personalized medicine. 3D printing in pharmaceuticals enables precise drug dosage customization, complex drug release profiles, and improved patient compliance, making it a transformative innovation in the healthcare industry. The...0 Commentaires 0 Parts 458 Vue 0 Aperçu
-
A Comprehensive Strategic Study Highlighting New Trends In Computational Medicine Software AnalysiA detailed Computational Medicine Drug Designing Software Market Analysis reveals that we are on the cusp of a significant paradigm shift in how research data is utilized. Current trends indicate a move toward integrating automated algorithms with existing molecular databases to improve the accuracy of drug predictions. For instance, enhanced sensors within the software can detect...0 Commentaires 0 Parts 451 Vue 0 Aperçu
-
Advanced Manufacturing Technologies Transform the U.S. Large Molecule CDMO MarketIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Commentaires 0 Parts 324 Vue 0 Aperçu
-
AI Clinical Trial Market Growing at 15% CAGR Through 2034According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
AI Drug Repurposing Market Growth is booming worldwide Analysis By Fact.MRU.S. AI Drug Repurposing Market Gains Momentum as Pfizer Expands AI-Driven Drug Discovery, with Global Market Rising from USD 1.5 billion in 2026 to USD 8.8 billion by 2036 at a 19.4% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The AI drug repurposing market crossed a valuation of USD 1.3 billion in 2025. Demand is projected to increase from USD 1.5 billion in 2026...0 Commentaires 0 Parts 233 Vue 0 Aperçu
-
AI Drug Repurposing Market Growth, Excellent Development of Fintech Block Chain with Key Vendors Analysis By Fact.MRROCKVILLE, MARYLAND , Sept 18, 2026 – The AI drug repurposing market crossed a valuation of USD 1.3 billion in 2025. Demand is projected to increase from USD 1.5 billion in 2026 to USD 8.8 billion by 2036, recording a 19.4% compound annual growth rate (CAGR) over the forecast period, according to Fact.MR analysis. Absolute opportunity stands at USD 7.3 billion by 2036. Get...0 Commentaires 0 Parts 524 Vue 0 Aperçu
-
Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in EuropeAlvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...0 Commentaires 0 Parts 14 Vue 0 Aperçu
-
Angioplasty Balloons Market Outlook: Innovation, Demand & Future GrowthAngioplasty Balloons Market: Advancing Minimally Invasive Cardiovascular Care Through Innovative Balloon Catheter Technologies Angioplasty Balloons Market Snapshot The Angioplasty Balloons Market is witnessing steady growth as healthcare providers increasingly adopt minimally invasive procedures for the treatment of coronary and peripheral artery diseases. According to M2Square...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Animal Drug Compounding Market Expansion Driven by Veterinary SpendingThe right medication is not always available in the right strength, dosage form, or flavor for every animal. A dog may struggle with tablets, a cat may require a carefully adjusted dose, and livestock may need treatment options that are not commercially available for a specific condition. These challenges are creating a growing role for customized veterinary medications and strengthening the...0 Commentaires 0 Parts 640 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek